|
4-Aminohydrocinnamic Acid
|
DB03210 |
|
|
(3-Formyl-but-3-Enyl)-Phosphonic Acid
|
DB03211 |
|
|
3'-Azido-3'-Deoxythymidine-5'-Diphosphate
|
DB04542 |
|
|
3-hydroxyglutaric acid
|
DB04594 |
|
|
Thiocellobiose
|
DB03263 |
|
|
Dodecyl-Coa
|
DB03264 |
|
|
(E)-(4S,6S)-8-METHYL-6-((S)-3-METHYL-2-{(S)-2-[(5-METHYL-ISOXAZOLE-3-CARBONYL)-AMINO]-PROPIONYLAMINO}-BUTYRYLAMINO)-5-OXO-4-((R)-2-OXO-PYRROLIDIN-3-YLMETHYL)-NON-2-ENOIC ACID BENZYL ESTER
|
DB04595 |
|
|
3-Bromo-3-buten-1-ol
|
DB04592 |
|
|
Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]
|
DB03262 |
|
|
3-({1-[3-CARBAMIMIDOYL-1-(4-CARBAMIMIDOYL-BENZYLCARBAMOYL)-PROPYLCARBAMOYL]-2-METHYL-BUTYLSULFAMOYL}-METHYL)-BENZOIC ACID
|
DB04593 |
|
|
(2R)-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO){5-ETHOXY-2-FLUORO-3-[(3R)-TETRAHYDROFURAN-3-YLOXY]PHENYL}ACETICACID
|
DB04590 |
|
|
1,6-Diaminohexane
|
DB03260 |
|
|
N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE
|
DB04591 |
|
|
MK-6325
|
DB15249 |
[MK-6325 is under investigation in clinical trial NCT01329913 (Safety, Pharmacokinetics, and Pharmacodynamics of MK-6325 in Hepatitis C Virus (HCV) Infections (MK-6325-003)).] |
|
Bulevirtide
|
DB15248 |
[Bulevirtide is under investigation in clinical trial NCT03852433 (Phase 2b Study of Bulevirtide (With Peginterferon Alfa-2a) in Patients With CHD).] |
|
Olorofim
|
DB15245 |
[Olorofim is under investigation in clinical trial NCT03340597 (Assessment of Varying Oral Dosing Regimens for F901318 in Healthy Subjects).] |
|
NM-404 I-131
|
DB15244 |
[NM-404 I-131 is under investigation in clinical trial NCT01495663 (Dose Escalation Study of I-131-CLR1404 in Subjects With Cancer That Does Not Respond to Treatment or Has Returned).] |
|
Vorolanib
|
DB15247 |
[Vorolanib is under investigation in clinical trial NCT03904719 (CM082 and JS001 in Patients With Advanced Small-cell Lung Cancer (SCLC)).] |
|
Salvianolic acid A
|
DB15246 |
[Salvianolic acid A is under investigation in clinical trial NCT03908242 (Phase I Study of Continuous Administration of Salvianolic Acid A Tablet).] |
|
Methylsamidorphan
|
DB15241 |
[Methylsamidorphan is under investigation in clinical trial NCT01418092 (ALK37-007: Evaluation of Safety and Efficacy of ALKS 37 (RDC-1036) in Adults With Opioid-induced Constipation (OIC)).] |
